Why Choose A Modular Automated Approach To Autologous CAR T Manufacturing?

Cell therapy manufacturers are navigating a pivotal moment as demand accelerates and processes grow more intricate. Many teams are encountering mounting pressures—unpredictable batch performance, resource-intensive workflows, and scale-up challenges that strain existing capacity. Recognizing where these issues concentrate is essential for safeguarding quality and unlocking sustainable growth.

This infographic brings the latest industry data into sharp focus, highlighting the most common sources of batch variability, the operational steps consuming disproportionate time and labor, and the strategic adjustments organizations are making to strengthen productivity. It’s a clear, data-driven look at how the field is shifting and where opportunities exist to improve reliability and throughput.

If you’re aiming to stay ahead of emerging bottlenecks, this visual snapshot offers a concise place to start.